Future studies by the use of SOD1-G93A transgenic mice depleted of either the histidine decarboxylase enzyme or the histamine H1R-H4R receptors will aim to prove this hypothesis that is in accordance with the administration of HSR-targeting drugs as therapeutics for ALS [10]. Here, SOD1 is linked to amyotrophic lateral sclerosis.